Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| METEORA CAPITAL, LLC | 5.37M | $1.0M | 4.43% | +5.37M | 2026-03-31 |
| UBS Group AG | 1.07M | -- | 0.89% | +556.4K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 740.5K | -- | 0.61% | +248.6K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 577.3K | -- | 0.48% | -- | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 371.7K | -- | 0.31% | -- | 2026-03-31 |
| Brummer Multi-Strategy AB | 370.0K | -- | 0.31% | -236.7K | 2026-03-31 |
| AM INVESTMENT STRATEGIES LLC | 200.0K | -- | 0.16% | -- | 2026-03-31 |
| STATE STREET CORP | 196.4K | -- | 0.16% | -- | 2026-03-31 |
| BlackRock, Inc. | 143.5K | -- | 0.12% | -- | 2026-03-31 |
| XTX Topco Ltd | 136.8K | -- | 0.11% | -23.8K | 2026-03-31 |
